Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Schwyz, Switzerland
Countries of investment
  • United Kingdom
Investment stages
  • Seed
  • Series A
  • Series B
Industries
  • Health Tech
  • Biotechnology
  • AI
  • Data science
About
Pureos Bioventures is a venture capital firm dedicated to investing in private companies that are pioneering the development of innovative therapeutics. Specializing in next-generation biological drugs, Pureos Bioventures aims to accelerate the advancement of treatments for severe diseases, ultimately enhancing patient outcomes and quality of life. By leveraging deep industry expertise and strategic partnerships, the firm empowers its portfolio companies to bring transformative solutions to the healthcare landscape.
Min check size
$500K
Max check size
$5M
Fund size
NPS

Investment Thesis

Pureos Bioventures invests venture capital in private innovative drug development companies, with an emphasis on the next generation of biological drugs and drug formats. They strive to impact patients’ lives by advancing innovative treatments for severe diseases.
Lead investor
Co Invest
Number of exits
Preferred contact method

Pureos Bioventures Contacts Information

Primary contact

Secondary contact

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp